Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Food, Fortified | 8 | 2020 | 189 | 2.310 |
Why?
|
Folic Acid | 8 | 2024 | 1309 | 2.080 |
Why?
|
Dietary Supplements | 12 | 2024 | 3392 | 1.450 |
Why?
|
Poland | 12 | 2020 | 196 | 1.000 |
Why?
|
Micronutrients | 3 | 2019 | 381 | 0.990 |
Why?
|
Sarcoma, Alveolar Soft Part | 1 | 2024 | 43 | 0.940 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2024 | 317 | 0.900 |
Why?
|
Nutritional Requirements | 5 | 2013 | 275 | 0.880 |
Why?
|
Diet, Mediterranean | 4 | 2023 | 735 | 0.860 |
Why?
|
Food Analysis | 2 | 2013 | 103 | 0.790 |
Why?
|
Gastrointestinal Stromal Tumors | 7 | 2022 | 615 | 0.790 |
Why?
|
Folic Acid Deficiency | 3 | 2011 | 117 | 0.750 |
Why?
|
Leiomyosarcoma | 2 | 2022 | 424 | 0.740 |
Why?
|
Nutritional Status | 10 | 2024 | 1607 | 0.720 |
Why?
|
Vitamins | 4 | 2020 | 1634 | 0.700 |
Why?
|
Cyclins | 7 | 2018 | 593 | 0.660 |
Why?
|
Oncogene Proteins, Fusion | 2 | 2024 | 1596 | 0.630 |
Why?
|
Cyclin-Dependent Kinase 4 | 7 | 2024 | 556 | 0.590 |
Why?
|
Tetrahydrofolates | 1 | 2017 | 58 | 0.560 |
Why?
|
Cell Proliferation | 10 | 2024 | 10446 | 0.560 |
Why?
|
Gastrointestinal Neoplasms | 5 | 2022 | 951 | 0.510 |
Why?
|
Nutritive Value | 3 | 2013 | 349 | 0.480 |
Why?
|
Diet | 8 | 2023 | 8010 | 0.470 |
Why?
|
Students | 4 | 2024 | 1730 | 0.470 |
Why?
|
Homocysteine | 1 | 2017 | 640 | 0.450 |
Why?
|
Vitamin B Complex | 2 | 2017 | 297 | 0.430 |
Why?
|
Cyclin D3 | 7 | 2017 | 54 | 0.420 |
Why?
|
Proto-Oncogene Proteins c-kit | 7 | 2022 | 727 | 0.400 |
Why?
|
Xenograft Model Antitumor Assays | 11 | 2024 | 3584 | 0.390 |
Why?
|
Malnutrition | 3 | 2013 | 640 | 0.380 |
Why?
|
Colorectal Neoplasms | 8 | 2024 | 6853 | 0.380 |
Why?
|
Cell Cycle | 12 | 2017 | 2934 | 0.380 |
Why?
|
Educational Status | 1 | 2019 | 2515 | 0.380 |
Why?
|
Life Style | 2 | 2022 | 3896 | 0.380 |
Why?
|
Cyclin-Dependent Kinase 6 | 4 | 2022 | 346 | 0.370 |
Why?
|
Vitamin B 12 Deficiency | 1 | 2012 | 119 | 0.360 |
Why?
|
Social Class | 2 | 2019 | 2005 | 0.360 |
Why?
|
Cell Line, Tumor | 26 | 2024 | 16939 | 0.360 |
Why?
|
Liposarcoma | 4 | 2014 | 283 | 0.340 |
Why?
|
Health Status | 2 | 2019 | 4081 | 0.340 |
Why?
|
Minerals | 3 | 2020 | 283 | 0.340 |
Why?
|
Vitamin B 12 | 1 | 2012 | 522 | 0.320 |
Why?
|
Universities | 2 | 2024 | 992 | 0.290 |
Why?
|
Health Behavior | 1 | 2019 | 2622 | 0.290 |
Why?
|
Nutrition Policy | 4 | 2016 | 470 | 0.280 |
Why?
|
Food Supply | 1 | 2013 | 542 | 0.280 |
Why?
|
Pancreatic Neoplasms | 5 | 2023 | 5351 | 0.280 |
Why?
|
Carcinoma, Pancreatic Ductal | 3 | 2023 | 1724 | 0.260 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2020 | 698 | 0.260 |
Why?
|
Attitude to Health | 2 | 2012 | 2029 | 0.250 |
Why?
|
Neuroendocrine Tumors | 2 | 2023 | 650 | 0.250 |
Why?
|
Receptor Protein-Tyrosine Kinases | 4 | 2022 | 1613 | 0.230 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2006 | 629 | 0.220 |
Why?
|
Leukemia, T-Cell | 1 | 2003 | 101 | 0.220 |
Why?
|
Mice | 33 | 2024 | 81208 | 0.220 |
Why?
|
Cyclin D1 | 5 | 2006 | 451 | 0.220 |
Why?
|
Cyclin E | 3 | 2018 | 155 | 0.210 |
Why?
|
Fusobacterium nucleatum | 1 | 2024 | 165 | 0.210 |
Why?
|
Tumor Microenvironment | 4 | 2023 | 3844 | 0.200 |
Why?
|
Succinate Dehydrogenase | 2 | 2019 | 145 | 0.190 |
Why?
|
Apoptosis | 7 | 2023 | 9501 | 0.190 |
Why?
|
Stomach Neoplasms | 2 | 2023 | 1423 | 0.190 |
Why?
|
Gene Expression Regulation, Neoplastic | 6 | 2024 | 8515 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-jun | 2 | 2014 | 285 | 0.190 |
Why?
|
Humans | 70 | 2024 | 760621 | 0.190 |
Why?
|
Intestinal Neoplasms | 1 | 2023 | 311 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 5 | 2021 | 5643 | 0.180 |
Why?
|
Histone Acetyltransferases | 1 | 2022 | 337 | 0.180 |
Why?
|
Animals | 38 | 2024 | 167963 | 0.170 |
Why?
|
Urban Population | 2 | 2011 | 2022 | 0.170 |
Why?
|
Sequence Analysis, RNA | 3 | 2022 | 2005 | 0.170 |
Why?
|
Cell Differentiation | 8 | 2017 | 11481 | 0.160 |
Why?
|
Asparaginase | 1 | 2020 | 240 | 0.160 |
Why?
|
Mice, Nude | 8 | 2019 | 3607 | 0.160 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2023 | 377 | 0.160 |
Why?
|
Female | 36 | 2024 | 391270 | 0.150 |
Why?
|
Neoplasms, Experimental | 2 | 2020 | 1229 | 0.150 |
Why?
|
Population Surveillance | 2 | 2013 | 2608 | 0.150 |
Why?
|
Esophageal Neoplasms | 3 | 2020 | 1648 | 0.150 |
Why?
|
Fusobacterium | 1 | 2017 | 54 | 0.150 |
Why?
|
Vitamin A | 1 | 2020 | 613 | 0.140 |
Why?
|
Mouth Neoplasms | 1 | 2022 | 593 | 0.140 |
Why?
|
Demography | 1 | 2022 | 1650 | 0.140 |
Why?
|
Endogenous Retroviruses | 1 | 2018 | 111 | 0.140 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2022 | 2058 | 0.130 |
Why?
|
Uterus | 1 | 2020 | 651 | 0.130 |
Why?
|
Metronidazole | 1 | 2017 | 231 | 0.130 |
Why?
|
Infertility | 1 | 2023 | 655 | 0.130 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2022 | 2864 | 0.130 |
Why?
|
Enhancer Elements, Genetic | 2 | 2019 | 1356 | 0.130 |
Why?
|
Lymphocytes | 1 | 2003 | 2611 | 0.130 |
Why?
|
Barrett Esophagus | 2 | 2020 | 490 | 0.130 |
Why?
|
Karyopherins | 1 | 2016 | 130 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2022 | 9411 | 0.120 |
Why?
|
MAP Kinase Signaling System | 3 | 2018 | 1484 | 0.120 |
Why?
|
Genes, Neoplasm | 1 | 2017 | 370 | 0.120 |
Why?
|
DNA Copy Number Variations | 1 | 2024 | 2013 | 0.120 |
Why?
|
Dermatofibrosarcoma | 1 | 2015 | 48 | 0.120 |
Why?
|
Antigens, Protozoan | 1 | 2017 | 316 | 0.120 |
Why?
|
Interferons | 1 | 2018 | 705 | 0.120 |
Why?
|
Gene Expression | 4 | 2022 | 7588 | 0.120 |
Why?
|
Hydrazines | 1 | 2016 | 224 | 0.120 |
Why?
|
Carcinoma, Squamous Cell | 2 | 2022 | 4024 | 0.120 |
Why?
|
Triazoles | 2 | 2019 | 904 | 0.120 |
Why?
|
Enzyme Activators | 1 | 2014 | 57 | 0.110 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2024 | 2873 | 0.110 |
Why?
|
Sarcoma | 2 | 2016 | 1786 | 0.110 |
Why?
|
Neovascularization, Pathologic | 1 | 2024 | 2640 | 0.110 |
Why?
|
Oncogenes | 1 | 2019 | 1220 | 0.110 |
Why?
|
Neutrophils | 1 | 2006 | 3767 | 0.110 |
Why?
|
Young Adult | 6 | 2020 | 58741 | 0.110 |
Why?
|
Feeding Behavior | 2 | 2019 | 3185 | 0.110 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2014 | 199 | 0.110 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2919 | 0.110 |
Why?
|
Liver Neoplasms | 3 | 2018 | 4319 | 0.110 |
Why?
|
Chromosome Aberrations | 1 | 2019 | 1764 | 0.110 |
Why?
|
Precancerous Conditions | 1 | 2020 | 977 | 0.110 |
Why?
|
Mice, Knockout | 10 | 2020 | 14372 | 0.100 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1889 | 0.100 |
Why?
|
Policy Making | 2 | 2014 | 538 | 0.100 |
Why?
|
Male | 28 | 2022 | 359744 | 0.100 |
Why?
|
Cyclin-Dependent Kinase 2 | 3 | 2022 | 183 | 0.100 |
Why?
|
Lipogenesis | 1 | 2014 | 210 | 0.100 |
Why?
|
Rural Population | 1 | 2003 | 2268 | 0.100 |
Why?
|
Neoplasm Proteins | 1 | 2024 | 3610 | 0.100 |
Why?
|
Cyclin D2 | 4 | 2005 | 98 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2017 | 1246 | 0.100 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18137 | 0.100 |
Why?
|
Mucous Membrane | 1 | 2015 | 657 | 0.100 |
Why?
|
Transcription Factors | 4 | 2022 | 12103 | 0.100 |
Why?
|
Schools | 1 | 2020 | 1480 | 0.100 |
Why?
|
Exercise | 2 | 2019 | 5787 | 0.100 |
Why?
|
Food Preferences | 2 | 2012 | 399 | 0.100 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2016 | 854 | 0.100 |
Why?
|
Mutation | 10 | 2024 | 29932 | 0.100 |
Why?
|
MicroRNAs | 2 | 2017 | 3790 | 0.090 |
Why?
|
Adenocarcinoma | 3 | 2020 | 6315 | 0.090 |
Why?
|
Chondrosarcoma | 1 | 2013 | 296 | 0.090 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2014 | 600 | 0.090 |
Why?
|
Body Mass Index | 2 | 2019 | 12914 | 0.090 |
Why?
|
Adult | 11 | 2021 | 219994 | 0.090 |
Why?
|
Uncertainty | 1 | 2014 | 754 | 0.080 |
Why?
|
Gene Amplification | 3 | 2024 | 1085 | 0.080 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2019 | 5253 | 0.080 |
Why?
|
Neural Tube Defects | 1 | 2011 | 254 | 0.080 |
Why?
|
Colonic Neoplasms | 1 | 2020 | 2526 | 0.080 |
Why?
|
Quinolines | 1 | 2013 | 759 | 0.070 |
Why?
|
Food Services | 1 | 2011 | 205 | 0.070 |
Why?
|
DNA Fragmentation | 1 | 2007 | 237 | 0.070 |
Why?
|
Imidazoles | 1 | 2013 | 1180 | 0.070 |
Why?
|
Receptors, Granulocyte Colony-Stimulating Factor | 1 | 2006 | 21 | 0.070 |
Why?
|
Carbon-Nitrogen Lyases | 1 | 2006 | 8 | 0.070 |
Why?
|
Neoplasms | 4 | 2023 | 22072 | 0.070 |
Why?
|
Organ Transplantation | 1 | 2017 | 1150 | 0.070 |
Why?
|
Blotting, Western | 5 | 2016 | 5039 | 0.070 |
Why?
|
Prostatic Neoplasms | 4 | 2014 | 11345 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2013 | 2448 | 0.070 |
Why?
|
Enzyme Activation | 4 | 2017 | 3602 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2018 | 3047 | 0.070 |
Why?
|
Disease Progression | 6 | 2022 | 13502 | 0.070 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3446 | 0.070 |
Why?
|
Repressor Proteins | 1 | 2017 | 2981 | 0.060 |
Why?
|
Phosphorylation | 5 | 2017 | 8313 | 0.060 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2018 | 367 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7806 | 0.060 |
Why?
|
RNA, Small Interfering | 4 | 2014 | 3442 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3164 | 0.060 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2007 | 330 | 0.060 |
Why?
|
Receptor, erbB-2 | 2 | 2024 | 2554 | 0.060 |
Why?
|
Cell Lineage | 2 | 2019 | 2533 | 0.060 |
Why?
|
Lymphocyte Specific Protein Tyrosine Kinase p56(lck) | 1 | 2003 | 93 | 0.060 |
Why?
|
Chronic Disease | 1 | 2019 | 9287 | 0.060 |
Why?
|
Retinoblastoma Protein | 3 | 2015 | 670 | 0.060 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2023 | 454 | 0.060 |
Why?
|
Proteins | 1 | 2019 | 6029 | 0.060 |
Why?
|
Pregnancy | 4 | 2016 | 29749 | 0.060 |
Why?
|
Neoplasms, Hormone-Dependent | 1 | 2006 | 412 | 0.060 |
Why?
|
Aged | 10 | 2021 | 169152 | 0.050 |
Why?
|
Embryo, Mammalian | 3 | 2004 | 1674 | 0.050 |
Why?
|
Blood Pressure | 1 | 2019 | 8525 | 0.050 |
Why?
|
Anemia, Megaloblastic | 1 | 2002 | 24 | 0.050 |
Why?
|
Erythrocytes | 1 | 2012 | 2415 | 0.050 |
Why?
|
Mammary Neoplasms, Experimental | 1 | 2006 | 507 | 0.050 |
Why?
|
Genetic Variation | 1 | 2018 | 6551 | 0.050 |
Why?
|
Double-Blind Method | 1 | 2017 | 12427 | 0.050 |
Why?
|
Purines | 2 | 2017 | 605 | 0.050 |
Why?
|
Endopeptidases | 1 | 2006 | 772 | 0.050 |
Why?
|
Adipocytes | 1 | 2009 | 1179 | 0.050 |
Why?
|
Aminopyridines | 2 | 2017 | 564 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5794 | 0.050 |
Why?
|
Cell Movement | 1 | 2014 | 5206 | 0.050 |
Why?
|
Dysmenorrhea | 1 | 2023 | 98 | 0.050 |
Why?
|
Adolescent | 2 | 2020 | 87810 | 0.050 |
Why?
|
Mouth | 1 | 2024 | 380 | 0.050 |
Why?
|
Single-Cell Analysis | 2 | 2023 | 2380 | 0.050 |
Why?
|
Diet, Vegetarian | 1 | 2023 | 180 | 0.050 |
Why?
|
Neutropenia | 1 | 2006 | 884 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2013 | 2532 | 0.050 |
Why?
|
Vitamin D | 1 | 2014 | 3291 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 631 | 0.040 |
Why?
|
Methylnitrosourea | 1 | 2020 | 30 | 0.040 |
Why?
|
Inflammation | 1 | 2020 | 10756 | 0.040 |
Why?
|
Child | 4 | 2019 | 79806 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2023 | 642 | 0.040 |
Why?
|
Fibroblast Growth Factor 4 | 1 | 2019 | 28 | 0.040 |
Why?
|
Receptors, Androgen | 1 | 2006 | 1077 | 0.040 |
Why?
|
Child Nutritional Physiological Phenomena | 2 | 2012 | 295 | 0.040 |
Why?
|
Disease Susceptibility | 1 | 2006 | 1791 | 0.040 |
Why?
|
Public Health | 1 | 2013 | 2653 | 0.040 |
Why?
|
Middle Aged | 8 | 2021 | 220352 | 0.040 |
Why?
|
HEK293 Cells | 2 | 2019 | 4264 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 7408 | 0.040 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2017 | 1728 | 0.040 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2019 | 192 | 0.040 |
Why?
|
Genome, Bacterial | 1 | 2024 | 770 | 0.040 |
Why?
|
Receptors, Notch | 1 | 2003 | 743 | 0.040 |
Why?
|
Bone Marrow Cells | 1 | 2006 | 2414 | 0.040 |
Why?
|
Esters | 1 | 1999 | 211 | 0.040 |
Why?
|
Islets of Langerhans | 1 | 2005 | 1345 | 0.040 |
Why?
|
Hypertension | 1 | 2019 | 8594 | 0.040 |
Why?
|
Health Promotion | 1 | 2011 | 2206 | 0.040 |
Why?
|
Mice, Transgenic | 3 | 2020 | 9530 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 22023 | 0.040 |
Why?
|
Neoplasm Transplantation | 2 | 2014 | 2014 | 0.040 |
Why?
|
Bacterial Infections | 1 | 2006 | 1403 | 0.040 |
Why?
|
RNA, Antisense | 1 | 2018 | 136 | 0.040 |
Why?
|
Gastrointestinal Tract | 1 | 2024 | 830 | 0.040 |
Why?
|
Prevotella | 1 | 2017 | 80 | 0.040 |
Why?
|
Phosphofructokinase-1 | 1 | 2017 | 51 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2019 | 25942 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2022 | 820 | 0.040 |
Why?
|
Child Welfare | 2 | 2012 | 516 | 0.040 |
Why?
|
HT29 Cells | 1 | 2017 | 190 | 0.040 |
Why?
|
Epigenesis, Genetic | 2 | 2022 | 3758 | 0.040 |
Why?
|
Reactive Nitrogen Species | 1 | 2017 | 35 | 0.040 |
Why?
|
Feces | 1 | 2024 | 1455 | 0.040 |
Why?
|
Bacteroides | 1 | 2017 | 165 | 0.040 |
Why?
|
Models, Animal | 1 | 2003 | 2117 | 0.040 |
Why?
|
Cell Line | 3 | 2019 | 15620 | 0.040 |
Why?
|
Cricetulus | 1 | 2019 | 815 | 0.040 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2018 | 190 | 0.030 |
Why?
|
Pentose Phosphate Pathway | 1 | 2017 | 126 | 0.030 |
Why?
|
Fallopian Tubes | 1 | 2017 | 178 | 0.030 |
Why?
|
Azepines | 1 | 2019 | 330 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 2 | 2006 | 3387 | 0.030 |
Why?
|
raf Kinases | 1 | 2017 | 118 | 0.030 |
Why?
|
Systole | 1 | 2019 | 947 | 0.030 |
Why?
|
Cell Survival | 2 | 2017 | 5797 | 0.030 |
Why?
|
Aged, 80 and over | 4 | 2018 | 58995 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2004 | 5870 | 0.030 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 286 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2019 | 629 | 0.030 |
Why?
|
CHO Cells | 1 | 2019 | 1389 | 0.030 |
Why?
|
Gene Silencing | 2 | 2017 | 1513 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2003 | 6131 | 0.030 |
Why?
|
Molecular Targeted Therapy | 2 | 2021 | 2803 | 0.030 |
Why?
|
HCT116 Cells | 1 | 2017 | 402 | 0.030 |
Why?
|
Immunohistochemistry | 3 | 2015 | 11071 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2019 | 529 | 0.030 |
Why?
|
Neurofibromin 1 | 1 | 2017 | 190 | 0.030 |
Why?
|
Pyruvate Kinase | 1 | 2017 | 190 | 0.030 |
Why?
|
Longevity | 1 | 2023 | 1050 | 0.030 |
Why?
|
Neoplasm Metastasis | 2 | 2017 | 4902 | 0.030 |
Why?
|
Cerebellum | 1 | 2002 | 1496 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3775 | 0.030 |
Why?
|
Pyridines | 2 | 2019 | 2879 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2017 | 514 | 0.030 |
Why?
|
Mice, Inbred Strains | 1 | 2017 | 1763 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2017 | 384 | 0.030 |
Why?
|
Genome, Human | 1 | 2007 | 4417 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2017 | 13630 | 0.030 |
Why?
|
Respiratory Mucosa | 1 | 2017 | 441 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2015 | 256 | 0.030 |
Why?
|
New Zealand | 1 | 2014 | 355 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 729 | 0.030 |
Why?
|
Oncogene Proteins | 1 | 2018 | 719 | 0.030 |
Why?
|
Cell Dedifferentiation | 1 | 2014 | 122 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2010 | 2506 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2016 | 717 | 0.030 |
Why?
|
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 381 | 0.030 |
Why?
|
Bone Marrow | 1 | 2003 | 2912 | 0.030 |
Why?
|
Serine | 1 | 2017 | 830 | 0.030 |
Why?
|
Cilia | 1 | 2017 | 493 | 0.030 |
Why?
|
Adenoma | 1 | 2024 | 2148 | 0.030 |
Why?
|
Spain | 1 | 2014 | 488 | 0.030 |
Why?
|
Interleukin-13 | 1 | 2015 | 371 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2004 | 3604 | 0.030 |
Why?
|
Glycolysis | 1 | 2017 | 828 | 0.030 |
Why?
|
Telomere | 1 | 2019 | 933 | 0.030 |
Why?
|
Signal Transduction | 3 | 2016 | 23376 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 2006 | 4742 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2013 | 465 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2013 | 7850 | 0.030 |
Why?
|
Gene Fusion | 1 | 2015 | 354 | 0.030 |
Why?
|
Chromosome Deletion | 1 | 2017 | 1387 | 0.030 |
Why?
|
Nervous System Diseases | 1 | 2002 | 1647 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1139 | 0.020 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2017 | 730 | 0.020 |
Why?
|
Fatty Acids | 1 | 1999 | 1804 | 0.020 |
Why?
|
Collagen Type I | 1 | 2015 | 616 | 0.020 |
Why?
|
Evidence-Based Medicine | 2 | 2014 | 3696 | 0.020 |
Why?
|
Pyridones | 1 | 2017 | 792 | 0.020 |
Why?
|
Tissue Array Analysis | 1 | 2013 | 551 | 0.020 |
Why?
|
Interleukin-4 | 1 | 2015 | 1130 | 0.020 |
Why?
|
K562 Cells | 1 | 2012 | 640 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2013 | 476 | 0.020 |
Why?
|
Australia | 1 | 2014 | 1289 | 0.020 |
Why?
|
Chromatin | 1 | 2022 | 2938 | 0.020 |
Why?
|
Cell Size | 1 | 2012 | 624 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2018 | 1841 | 0.020 |
Why?
|
Gene Dosage | 1 | 2014 | 1218 | 0.020 |
Why?
|
Homeodomain Proteins | 1 | 2019 | 2414 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2013 | 518 | 0.020 |
Why?
|
Netherlands | 1 | 2014 | 2213 | 0.020 |
Why?
|
Genes, jun | 1 | 2009 | 68 | 0.020 |
Why?
|
MAP Kinase Kinase Kinase 5 | 1 | 2009 | 20 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3817 | 0.020 |
Why?
|
Trans-Activators | 1 | 2019 | 2860 | 0.020 |
Why?
|
Gene Regulatory Networks | 1 | 2018 | 1741 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2024 | 65017 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2017 | 2138 | 0.020 |
Why?
|
Tumor Burden | 1 | 2015 | 1895 | 0.020 |
Why?
|
Genes, p53 | 1 | 2011 | 713 | 0.020 |
Why?
|
DNA Repair | 1 | 2018 | 2039 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 4573 | 0.020 |
Why?
|
Erythropoiesis | 1 | 2012 | 682 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2017 | 4107 | 0.020 |
Why?
|
Transfection | 2 | 2006 | 5781 | 0.020 |
Why?
|
Cell Count | 1 | 2012 | 1835 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2021 | 39261 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1617 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2013 | 1376 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2018 | 6828 | 0.020 |
Why?
|
Time Factors | 4 | 2019 | 40165 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2014 | 18957 | 0.020 |
Why?
|
Medical Oncology | 1 | 2019 | 2313 | 0.020 |
Why?
|
Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 2007 | 78 | 0.020 |
Why?
|
Gene Deletion | 1 | 2015 | 2668 | 0.020 |
Why?
|
Temperature | 2 | 2007 | 2221 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2007 | 6068 | 0.020 |
Why?
|
Parent-Child Relations | 1 | 2012 | 758 | 0.020 |
Why?
|
Food | 1 | 2012 | 771 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 1 | 2019 | 4490 | 0.020 |
Why?
|
Alcohol Drinking | 1 | 1999 | 4013 | 0.020 |
Why?
|
Family Characteristics | 1 | 2012 | 1001 | 0.020 |
Why?
|
Down-Regulation | 1 | 2014 | 2913 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2005 | 5889 | 0.020 |
Why?
|
Tissue Fixation | 1 | 2007 | 241 | 0.020 |
Why?
|
RNA Interference | 1 | 2015 | 2846 | 0.020 |
Why?
|
Colony-Forming Units Assay | 1 | 2006 | 351 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 4035 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2024 | 22053 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2017 | 3106 | 0.020 |
Why?
|
Cell Division | 2 | 2004 | 4463 | 0.020 |
Why?
|
Europe | 1 | 2013 | 3441 | 0.020 |
Why?
|
Formaldehyde | 1 | 2007 | 358 | 0.020 |
Why?
|
Dihydrotestosterone | 1 | 2006 | 195 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2221 | 0.020 |
Why?
|
Cell Growth Processes | 1 | 2006 | 384 | 0.020 |
Why?
|
Mice, Inbred NOD | 1 | 2010 | 1837 | 0.020 |
Why?
|
Soft Tissue Neoplasms | 1 | 2014 | 1152 | 0.020 |
Why?
|
Androgen Receptor Antagonists | 1 | 2006 | 123 | 0.020 |
Why?
|
Nanoparticles | 1 | 2017 | 1943 | 0.020 |
Why?
|
Genes, erbB-2 | 1 | 2006 | 162 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4373 | 0.020 |
Why?
|
Protein Processing, Post-Translational | 1 | 2013 | 1974 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2020 | 4412 | 0.020 |
Why?
|
Eating | 1 | 2012 | 1539 | 0.020 |
Why?
|
Methylcellulose | 1 | 2004 | 34 | 0.020 |
Why?
|
Aging | 1 | 2004 | 8651 | 0.020 |
Why?
|
Cyclin A | 1 | 2004 | 60 | 0.010 |
Why?
|
Mice, SCID | 1 | 2010 | 2627 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2015 | 15789 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2017 | 21025 | 0.010 |
Why?
|
Piperazines | 1 | 2015 | 2525 | 0.010 |
Why?
|
CDC2-CDC28 Kinases | 1 | 2004 | 110 | 0.010 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2004 | 2828 | 0.010 |
Why?
|
Phenotype | 2 | 2017 | 16546 | 0.010 |
Why?
|
Qualitative Research | 1 | 2014 | 2963 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2013 | 2566 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10827 | 0.010 |
Why?
|
Genetic Association Studies | 1 | 2013 | 2717 | 0.010 |
Why?
|
RNA, Neoplasm | 1 | 2006 | 749 | 0.010 |
Why?
|
Body Weight | 1 | 2014 | 4611 | 0.010 |
Why?
|
Hyperhomocysteinemia | 1 | 2004 | 118 | 0.010 |
Why?
|
Glucagon | 1 | 2005 | 532 | 0.010 |
Why?
|
Protein Binding | 2 | 2006 | 9335 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2004 | 1543 | 0.010 |
Why?
|
Cardiovascular Abnormalities | 1 | 2003 | 143 | 0.010 |
Why?
|
Spermatogenesis | 1 | 2003 | 257 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 2002 | 420 | 0.010 |
Why?
|
DNA, Neoplasm | 1 | 2007 | 1745 | 0.010 |
Why?
|
Trophoblasts | 1 | 2003 | 224 | 0.010 |
Why?
|
Genes, myc | 1 | 2002 | 395 | 0.010 |
Why?
|
Ubiquitin | 1 | 2006 | 838 | 0.010 |
Why?
|
Glucose Intolerance | 1 | 2005 | 580 | 0.010 |
Why?
|
Decision Making | 1 | 2014 | 3925 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 11152 | 0.010 |
Why?
|
Retroviridae | 1 | 2002 | 850 | 0.010 |
Why?
|
Zebrafish | 1 | 2011 | 2997 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29658 | 0.010 |
Why?
|
Gene Targeting | 1 | 2003 | 839 | 0.010 |
Why?
|
Prostate-Specific Antigen | 1 | 2010 | 2529 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2006 | 12766 | 0.010 |
Why?
|
Megakaryocytes | 1 | 2003 | 565 | 0.010 |
Why?
|
Blood Preservation | 1 | 1999 | 168 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 2002 | 1900 | 0.010 |
Why?
|
Androgens | 1 | 2006 | 1291 | 0.010 |
Why?
|
Alcoholic Beverages | 1 | 1999 | 264 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2017 | 12626 | 0.010 |
Why?
|
Health Education | 1 | 2004 | 1049 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2015 | 20080 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2006 | 6538 | 0.010 |
Why?
|
Algorithms | 1 | 2017 | 13981 | 0.010 |
Why?
|
DNA Replication | 1 | 2003 | 1412 | 0.010 |
Why?
|
Base Sequence | 1 | 2007 | 12446 | 0.010 |
Why?
|
Primary Prevention | 1 | 2004 | 1207 | 0.010 |
Why?
|
Cryopreservation | 1 | 1999 | 717 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2012 | 11903 | 0.010 |
Why?
|
Placenta | 1 | 2003 | 1702 | 0.010 |
Why?
|
Fibroblasts | 1 | 2004 | 4090 | 0.010 |
Why?
|
Triglycerides | 1 | 1999 | 2476 | 0.010 |
Why?
|
Stem Cells | 1 | 2004 | 3523 | 0.010 |
Why?
|
Blood Glucose | 1 | 2005 | 6381 | 0.010 |
Why?
|
Insulin | 1 | 2005 | 6597 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2019 | 80372 | 0.010 |
Why?
|
Cognition Disorders | 1 | 2004 | 3976 | 0.010 |
Why?
|
Models, Biological | 1 | 2004 | 9467 | 0.000 |
Why?
|
Sex Factors | 1 | 1999 | 10547 | 0.000 |
Why?
|
Cardiovascular Diseases | 1 | 2004 | 15757 | 0.000 |
Why?
|
Risk Factors | 1 | 2004 | 74359 | 0.000 |
Why?
|